Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery.
Ophira SalomonIvan BudnikEinat AvishaiIlia TamarinDalia BashariRima DardikTami LivnatPublished in: Thrombosis and haemostasis (2019)
A single very low dose of rFVIIa along with TXA is a simple and safe treatment to control hemostasis in severe FXI-deficient patients undergoing diverse type of surgical procedure at various sites.